0001179110-20-012216.txt : 20201223 0001179110-20-012216.hdr.sgml : 20201223 20201223160510 ACCESSION NUMBER: 0001179110-20-012216 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201221 FILED AS OF DATE: 20201223 DATE AS OF CHANGE: 20201223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Glass Geoffrey Michael CENTRAL INDEX KEY: 0001517718 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37977 FILM NUMBER: 201412267 MAIL ADDRESS: STREET 1: 4721 EMPEROR BLVD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001012477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK STREET 2: BALLYCOOLIN CITY: DUBLIN STATE: L2 ZIP: 15 BUSINESS PHONE: 636-449-1830 MAIL ADDRESS: STREET 1: 16640 CHESTERFIELD GROVE ROAD STREET 2: SUITE 200 CITY: CHESTERFIELD STATE: MO ZIP: 63005 FORMER COMPANY: FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA DATE OF NAME CHANGE: 19960422 4 1 edgar.xml FORM 4 - X0306 4 2020-12-21 0 0001012477 AVADEL PHARMACEUTICALS PLC AVDL 0001517718 Glass Geoffrey Michael C/O AVADEL PHARMACEUTICALS PLC 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 IRELAND 1 0 0 0 ADSs 2020-12-21 5 G 0 E 18600 0 D 47100 D ADSs 18600 I By Trust Stock Option (Right to Buy) 2.03 2020-12-21 5 G 0 E 60000 0 A 2029-08-07 ADSs 60000 0 D Stock Option (Right to Buy) 2.03 2029-08-07 ADSs 60000 60000 I By Trust Stock Option (Right to Buy) 8.48 2020-12-21 5 G 0 E 42000 0 A 2030-08-07 ADSs 42000 0 D Stock Option (Right to Buy) 8.48 2030-08-07 ADSs 42000 42000 I By Trust The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts. On December 21, 2020, the reporting person transferred 18,600 ADSs to a family trust of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust. On December 21, 2020, the reporting person transferred 60,000 options to a family trust of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust. Options become exercisable as to 20,000 ADSs on each of the first three anniversaries after the 08/07/2019 grant date. On December 21, 2020, the reporting person transferred 42,000 options to a family trust of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust. Options become exercisable as to 14,000 ADSs on each of the first three anniversaries after the 08/07/2020 grant date. /s/ Jerad Seurer, as attorney-in-fact 2020-12-23